Prota Therapeutics is a Melbourne-based biotechnology company focused on developing and commercialising treatments for food allergies. Its main mission is to improve the lives of people suffering from food allergies through the development of safe, effective and accessible treatments. Supported by the Melbourne Accelerator Program, Prota Therapeutics is built on over 15 years of clinical research in food allergy immunotherapy.

Their flagship product, a treatment for peanut allergies, is currently in late-stage clinical trials. The company is also actively pursuing the development of treatments for other common food allergies. By collaborating with leading researchers and medical professionals, Prota Therapeutics aims to make a significant impact in the field of food allergy treatment.

Connect